Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Predictmedix AI Inc > PMED & Hindalco Timeline getting closer
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(42)
•••
Post by marrcooooon Jul 16, 2020 9:50am
185 Views
Post# 31275199

PMED & Hindalco Timeline getting closer

PMED & Hindalco Timeline getting closerRahul from April 22 Hindalco Pilot the video at 5:15...

https://www.youtube.com/watch?v=OulzW4gjyjk

"Once the pilot is over and once we have sorted out all the kinks, there is a lot of eagerness from Hindalco's standpoint to use the technology in their premises and taking it a step further, once Hindalco latches onto it, your talking about the parent corporation which is actually much bigger than Hindalco with close to 150,000 employees all over the world."

From the April 22 News Release

- The pilot is expected to begin within the next two weeks and will utilize Predictmedix's proprietary AI powered impairment detection technology (patent pending) to identify cannabis and alcohol impairment. The pilot if uninterrupted, is expected to be completed within a 12-week period.-

This puts the roll out at July 29 assuming things went uninterupted.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities